Terms: = Uterine cancer AND ZFHX3, ATBT, 463, ENSG00000140836, Q15911 AND Staging
4 results:
1. Identification of a Multi-RNA-Type-Based Signature for Recurrence-Free Survival Prediction in Patients with uterine Corpus Endometrial Carcinoma.
Wang P; Zeng Z; Shen X; Tian X; Ye Q
DNA Cell Biol; 2020 Apr; 39(4):615-630. PubMed ID: 32105510
[TBL] [Abstract] [Full Text] [Related]
2. SOX17, β-catenin and CyclinD1 expression in the endometrioid adenocarcinoma and influence of 5-AZA on expression.
Liao YM; Song Y; Li YK; Du JH; Zhou Y
Cancer Gene Ther; 2020 Apr; 27(3-4):256-263. PubMed ID: 31543512
[TBL] [Abstract] [Full Text] [Related]
3. Stage I noninvasive and minimally invasive uterine serous carcinoma: comprehensive staging associated with improved survival.
Giuntoli RL; Gerardi MA; Yemelyanova AV; Ueda SM; Fleury AC; Diaz-Montes TP; Bristow RE
Int J Gynecol Cancer; 2012 Feb; 22(2):273-9. PubMed ID: 22146771
[TBL] [Abstract] [Full Text] [Related]
4. [Laparoscopic management of occult cervical cancer discovered after simple hysterectomy].
Vignancour S; Narducci F; Collinet P; Vinatier D; Castelain B; Leblanc E
Gynecol Obstet Fertil; 2007 Apr; 35(4):297-302. PubMed ID: 17337353
[TBL] [Abstract] [Full Text] [Related]
